Price caps will be mandated for five of the essential drugs after voluntary offers by the industry were found compliant only with respect to 16, the Health department said.
-
A draft executive order (EO) will be submitted by the department on or before Friday and President Gloria Macapagal-Arroyo is expected to sign it before she leaves for Washington next week, Executive Secretary Eduardo R. Ermita said.
Figuring in the 31 medicines covered by the “add-on” list, 99 branded products will have their prices cut on August 15, officials said.
-
Robert Louie P. So, program manager of the Health department’s National Drug Policy unit, declined to identify the specific drugs.
-
The 21 essential drugs are: anti-hypertensives amlodipine, telmisartan, irbesartan, clopidogrel, and atorvastatin; antidiabetic gliclazide; antibiotics piperacillin/tazobactam, ciprofloxacin, azithromycin, metronidazole, and co-amoxiclav; and the anticancer medicines bleomycin, carboplatin, cisplatin, cyclophosphamide, cytarabine, doxorubicin, etoposide, mercaptopurine, methotrexate, and mesna.
-
7/23/09 Business World http://www.bworldonline.com/BW072309/content.php?id=001&src=2
0 comments
Post a Comment